You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 109 No. 5, May 1962 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Acquired Hemolytic Anemia and Antipenicillin Antibody

Case Report and Review of Literature

P. V. STRUMIA, M.D.; F. D. RAYMOND, M.D.

Arch Intern Med. 1962;109(5):603-608.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In a recent report. Ley et al.1 have described the occurrence of circulating antipenicillin antibodies in patients who had received penicillin therapy. These antibodies were demonstrated by agglutination of penicillin-coated red blood cells by their sera. No agglutination of the same cells not coated with penicillin occurred with the same sera. Agglutination took place both by the saline and indirect antiglobulin technique. Cells coated with other antibiotics were not agglutinated by these sera. Eluates from the agglutinated cells agglutinated the penicillinized cells as well. Inhibition of agglutination was found after addition of penicillin to these sera prior to mixing with the test cells, but no inhibition was noted by addition of other antibiotics.

Penicillin has been used extensively since the first clinical trials in this country in 1942. In several large series2 approximately 1% to 8% of patients exhibited an allergic response to the drug, depending on the . . . [Full Text PDF of this Article]


Author Affiliations

BRYN MAWR, PA.

Laboratory of Clinical Pathology of The Bryn Mawr Hospital and The John S. Sharpe Research Foundation (Dr. Strumia); F. D. Raymond, M.D., Department of Medicine of The Bryn Mawr Hospital (Dr. Raymond).


Footnotes

Submitted for publication Jan. 25, 1961.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1962 American Medical Association. All Rights Reserved.